Article Information
History
- July 1, 2023.
Article Versions
- Version 1 (June 29, 2023 - 12:07).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Binod Dhungel1,
- Upendra Thapa Shrestha1,
- Sanjib Adhikari1,
- Nabaraj Adhikari1,
- Alisha Bhattarai2,
- Sunil Pokharel3,
- Abhilasha Karkey3,4,
- Direk Limmathurotsakul3,5,
- Prakash Ghimire1,
- Komal Raj Rijal1,
- Phaik Yeong Cheah3,5,
- Christopher Pell6 and
- Bipin Adhikari3,5,*
- 1Central Department of Microbiology, Tribhuvan University, Kathmandu, Nepal
- 2Manmohan Cardiothoracic Vascular and Transplant Center, Institute of Medicine, Tribhuvan University, Kathmandu, Nepal
- 3Center for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
- 4Oxford University Clinical Research Unit, Patan Academy of Health Sciences, Lalitpur, Nepal
- 5Mahidol-Oxford Tropical Medical Research Unit, Faculty of tropical Medicine, Mahidol University, Bangkok, Thailand
- 6Amsterdam Institute for Social Science Research, University of Amsterdam, Amsterdam, The Netherlands
- ↵*Corresponding author: Bipin Adhikari email: bipin{at}tropmedres.ac
Posted July 01, 2023.
Use of antimicrobials during the COVID-19 pandemic: a qualitative study among stakeholders in Nepal
